147 related articles for article (PubMed ID: 12827022)
1. Effect of magnesium on mRNA expression and production of endothelin-1 in DOCA-salt hypertensive rats.
Berthon N; Laurant P; Fellmann D; Berthelot A
J Cardiovasc Pharmacol; 2003 Jul; 42(1):24-31. PubMed ID: 12827022
[TBL] [Abstract][Full Text] [Related]
2. Magnesium supplementation and deoxycorticosterone acetate--salt hypertension: effect on arterial mechanical properties and on activity of endothelin-1.
Berthon N; Laurant P; Hayoz D; Fellmann D; Brunner HR; Berthelot A
Can J Physiol Pharmacol; 2002 Jun; 80(6):553-61. PubMed ID: 12117304
[TBL] [Abstract][Full Text] [Related]
3. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
[TBL] [Abstract][Full Text] [Related]
4. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
5. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
Allcock GH; Venema RC; Pollock DM
Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
[TBL] [Abstract][Full Text] [Related]
6. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
Ammarguellat F; Larouche I; Schiffrin EL
Circulation; 2001 Jan; 103(2):319-24. PubMed ID: 11208696
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats.
Schiffrin EL; Lariviere R; Li JS; Sventek P; Touyz RM
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S188-90. PubMed ID: 9072349
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism.
Sharifi AM; Schiffrin EL
J Hypertens; 1997 Dec; 15(12 Pt 1):1441-8. PubMed ID: 9431850
[TBL] [Abstract][Full Text] [Related]
11. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
Fujita K; Matsumura Y; Miyazaki Y; Hashimoto N; Takaoka M; Morimoto S
Life Sci; 1996; 58(1):PL1-7. PubMed ID: 8628104
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
Larivière R; Sventek P; Thibault G; Schiffrin EL
Can J Physiol Pharmacol; 1995 Mar; 73(3):390-8. PubMed ID: 7544236
[TBL] [Abstract][Full Text] [Related]
13. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
Giulumian AD; Pollock DM; Clarke N; Fuchs LC
Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
[TBL] [Abstract][Full Text] [Related]
14. Increased renal medullary endothelin-1 synthesis in prehypertensive DOCA- and salt-treated rats.
Hsieh TJ; Lin SR; Lee YJ; Shin SJ; Lai YH; Hsu CH; Tsai JH
Am J Physiol Renal Physiol; 2000 Jul; 279(1):F112-21. PubMed ID: 10894793
[TBL] [Abstract][Full Text] [Related]
15. Cardiac microvasculature in DOCA-salt hypertensive rats : effect of endothelin ET(A) receptor antagonism.
Larouche I; Schiffrin EL
Hypertension; 1999 Oct; 34(4 Pt 2):795-801. PubMed ID: 10523363
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
Schiffrin EL; Larivière R; Li JS; Sventek P
J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
[TBL] [Abstract][Full Text] [Related]
17. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
[TBL] [Abstract][Full Text] [Related]
18. Local administration of ETA (but not ETB) blockers into the PAG area of the brain decreases blood pressure of DOCA-salt rats.
Di Filippo C; D'Amico M; Piegari E; Rinaldi B; Filippelli A; Rossi F
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):123-6. PubMed ID: 12122498
[TBL] [Abstract][Full Text] [Related]
19. Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chung TH; Lin SZ; Chang NC
J Hypertens; 2014 Apr; 32(4):795-805. PubMed ID: 24463935
[TBL] [Abstract][Full Text] [Related]
20. Localization of sites of enhanced expression of endothelin-1 in the kidney of DOCA-salt hypertensive rats.
Deng LY; Day R; Schiffrin EL
J Am Soc Nephrol; 1996 Aug; 7(8):1158-64. PubMed ID: 8866407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
